Cancer Communications

Important notice

Cancer Communications will cease to publish with BioMed Central on 31^st December 2019. The journal is continuing in cooperation with a new publisher, Wiley starting from 2020. The new journal website is available at: https://onlinelibrary.wiley.com/journal/25233548.

The current submission site will be inactive on 31^st October 2019. Any new or revised manuscripts submitted after 1^st November 2019 should go to the new site: https://mc.manuscriptcentral.com/cac2. Please contact the editorial office at cancercommun@sysucc.org.cn for information regarding the new publisher and any submissions in progress.

Articles

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery

Authors: Liling Zhu, Shunrong Li, Luyuan Tan, Xiaolan Zhang, Jiannan Wu, Fengxi Su, Kai Chen and Erwei Song

Content type: Editorial

4 December 2019
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Authors: Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou and Sheng-Qing Lv

Content type: Original article

3 December 2019
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study

Authors: Jianqiu Kong, Junjiong Zheng, Jinhua Cai, Shaoxu Wu, Xiayao Diao, Weibin Xie, Xiong Chen, Chenyi Liao, Hao Yu, Xinxiang Fan, Chaowen Huang, Zhuowei Liu, Wei Chen, Qiang Lv, Haide Qin, Jian Huang…

Content type: Original article

27 November 2019
The immune landscape of esophageal cancer

Authors: Tu-Xiong Huang and Li Fu

Content type: Review

26 November 2019
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Authors: Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone and Kazuo Kasahara

Content type: Letter to the Editor

21 November 2019

Most recent articles RSS

View all articles

Predictive biomarkers in precision medicine and drug development against lung cancer

Authors: Bingliang Fang, Reza J Mehran, John V Heymach and Stephen G Swisher

Content type: Review

2 July 2015
The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Authors: Xue-Yan Zhang, Ge Zhang, Ying Jiang, Dan Liu, Man-Zhi Li, Qian Zhong, Shan-Qi Zeng, Wan-Li Liu and Mu-Sheng Zeng

Content type: Original article

10 August 2015
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Authors: Lu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, Qi Zeng, Chen Chen, An-Nan Dong, Zhi-Mei Huang, Chang-Chuan Pan, Yun-Fei Xia and Pei-Hong Wu

Content type: Original article

12 August 2015
Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Authors: Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li and Guangwu Huang

Content type: Original article

15 August 2015
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Authors: Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao and Rui-Hua Xu

Content type: Short report

29 April 2019

Most accessed articles RSS

View all articles

2018

Thematic series
Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

2017

Thematic series
Tumor Metastasis
Edited by Jian Zhang and Chao-Nan Qian

2016

Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian

2015

Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Editor-in-Chief

Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.

Cancer Communications

Important notice

Articles

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study

The immune landscape of esophageal cancer

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Predictive biomarkers in precision medicine and drug development against lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

2018

2017

2016

2015

Archival content

Thematic series

Aims and scope

Editor-in-Chief

Information for authors

Affiliated with

Follow

Annual Journal Metrics

Cancer Communications

Contact us